CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 78 filers reported holding CITIUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62,720 | -42.3% | 91,642 | +1.1% | 0.00% | 0.0% |
| Q2 2023 | $108,770 | +1.1% | 90,642 | -1.4% | 0.00% | 0.0% |
| Q1 2023 | $107,543 | +45.3% | 91,917 | -1.9% | 0.00% | 0.0% |
| Q4 2022 | $74,036 | -99.9% | 93,717 | -46.9% | 0.00% | 0.0% |
| Q3 2022 | $107,107,000 | +164680.0% | 176,344 | +148.0% | 0.00% | 0.0% |
| Q2 2022 | $65,000 | -9.7% | 71,102 | +77.1% | 0.00% | 0.0% |
| Q1 2022 | $72,000 | +7.5% | 40,137 | -7.2% | 0.00% | 0.0% |
| Q4 2021 | $67,000 | -19.3% | 43,237 | +5.6% | 0.00% | 0.0% |
| Q3 2021 | $83,000 | – | 40,958 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 196,867 | $181,000 | 0.05% |
| Wealth Advisory Solutions, LLC | 156,850 | $144,000 | 0.04% |
| Horst & Graben Wealth Management LLC | 75,722 | $70,000 | 0.02% |
| Ergoteles LLC | 451,890 | $416,000 | 0.01% |
| Miller Investment Management, LP | 50,000 | $46,000 | 0.01% |
| Virtu Financial LLC | 81,410 | $75,000 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 17,342 | $16,000 | 0.00% |
| Kestra Advisory Services, LLC | 71,102 | $65,000 | 0.00% |
| Csenge Advisory Group | 15,000 | $14,000 | 0.00% |
| Qube Research & Technologies Ltd | 121,281 | $112,000 | 0.00% |